相关实验视频
Updated: Jan 18, 2026

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
19.0K
益生菌对精神分裂症患者认知表现的混合作用
Meijuan Li1, Xiaoli Wang1, Xiaojing Zhou1
1Laboratory of Biological Psychiatry, Tianjin Anding Hospital, No. 13 Liulin Road, Hexi District, Tianjin, 300222, China.
概括
轻微升高的益生菌水平可能有利于精神分裂症患者的认知. 这项研究发现了益生菌和认知表现之间的反向U形关系,这表明这种荷尔蒙具有复杂的作用.
科学领域:
- 神经内分泌学神经内分泌学
- 精神病学是一个精神病学.
- 认知神经科学 认知神经科学
背景情况:
- 益生菌会影响认知,但其在精神分裂症中的作用仍未得到充分研究.
- 在精神分裂症患者中,高血糖性血是常见的.
- 目前关于益乳素和精神分裂症认知的研究是有限的.
研究的目的:
- 为了研究血清前素水平和精神分裂症患者的认知功能之间的关系.
- 为了确定益生菌度是否影响特定的认知领域.
- 为了探索前素水平及其认知关联的潜在性别差异.
主要方法:
- 在113名精神分裂症患者中测量了血清前素度.
- 使用 MATRICS 共识认知电池 (MCCB) 评估认知功能.
- 统计分析检查了益生素水平和认知测试得分之间的相关性,包括简要视觉空间记忆测试修订 (BVMT-R) 和霍普金斯口语学习测试修订 (HVLT-R).
主要成果:
- 在74.3%的患者中观察到过高乳糖血症.
- 女性患者表现出明显更高的益生菌度比男性患者.
- 在BVMT-R和HVLT-R上的益生菌水平和表现之间发现了反向的U形关系.
结论:
- 益生菌对精神分裂症的认知表现产生混合作用,取决于度.
- 轻微升高的益乳素水平可能与改善的认知功能有关.
- 这些发现突出了精神分裂症中复杂的神经内分泌-认知相互作用.
相关概念视频
Negative and Cognitive Symptoms of Schizophrenia
475
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
475
Psychosis: Goals of Pharmacotherapy
476
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
476
Psychosis and Antipsychotic Drugs: Overview
820
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
820
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
563
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
563
Psychological and Sociocultural Causes of Schizophrenia
482
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
482
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K

